Greenfield, brownfield or O&M: what each does to the brand

When a group decides to add a unit, the executive committee debates three routes: build it, buy it, or run someone else’s. Greenfield, brownfield, operations and management. The debate is usually about capital, timeline and control, and those are the right things to debate. What almost never comes up is what each route does to the brand — and, more practically, what demand engine the group will have to build, inherit or untangle on the other side.

I have sat in the launch plan for all three. They are not the same job with different budgets. A greenfield gives you a blank slate and nothing to stand on. A brownfield gives you a running hospital with someone else’s name on every listing, every review and every doctor’s visiting card. An O&M gives you a hospital you do not own, a brand you may only partly control, and a contract that decides who keeps the digital assets when it ends.

This article is what the growth and digital function should put in front of the committee before the route is chosen, not after. Because by the time the deal is signed, most of what follows is already decided.

Greenfield: nothing to inherit, nothing to stand on

A new build is the cleanest brand case and the hardest demand case. The name is yours, the entity is yours, the site and the listings are created from zero with no history to correct. That is the good news, and it is real: no legacy reviews, no duplicate maps pins, no domain with a decade of someone else’s content.

The bad news is that from a demand point of view you are starting twelve to eighteen months before opening with no doctors to name, no address that resolves on a map, and — unless the group already has branded search in that city — no reason for anyone to type your name. The demand engine has to be built entirely from the group brand and from whatever clinical leadership you can announce early. If the group’s name carries in that catchment, the ramp is shorter. If it does not, the plan leans on the doctors you hire, and every one of them arrives with their own following that you are borrowing, not owning.

The digital work is long but linear: entity created early and verified, a site that exists before the building does, listings claimed the moment the address is legal, a contact centre queue set up before the phones ring, and a CRM that captures pre-launch enquiries so that opening week has a list to call. I have written elsewhere about the pre-launch phase; the point here is that a greenfield buys brand cleanliness at the price of a longer, more expensive demand build, and the capital case should carry that cost explicitly rather than assuming the flagship’s ramp.

Brownfield: buying a hospital means buying its footprint

An acquisition looks, from the committee’s side, like the fast route: beds, licences, doctors and patients on day one. From the brand’s side, it is the messiest. You are buying a digital footprint that was built by someone else, to different standards, and it does not stop existing when the sale closes.

Three things arrive with the deal whether you want them or not.

The entity and the name. The hospital has a legal name, a trading name that may differ, a domain, a maps listing that may or may not be claimed, and a set of aggregator profiles that the previous management may never have controlled. The name is known locally — that is part of what you paid for — and the decision on whether to keep it, replace it or hyphenate it is the single largest brand decision in the whole transaction. It is usually made late, by people thinking about signage.

The reviews. Every rating the old hospital earned is attached to the listing you are inheriting. If the unit was well run, this is an asset the greenfield never gets. If it was not, you are opening under a score that your own operations did not produce. Renaming the listing does not reset the reviews; changing the entity might, and it also loses whatever equity was there. There is no clean answer, and the digital function should be the one to lay out the options with the review history actually in hand.

The doctors’ brands. In most Indian acquisitions, the patient base belongs to the senior doctors more than to the hospital. Their names are what the catchment searches for. If they stay, the demand engine transfers with them. If they leave — and a change of ownership is exactly when they consider it — the enquiry data you saw in diligence walks out with them. Doctor retention is an HR and medical-director conversation; doctor-brand transfer is a digital one, and it starts with knowing which doctors’ pages actually carry the traffic.

The rename decision, honestly

There are three options and I have seen each go wrong.

Keep the local name and add the group as an endorsement — “X Hospital, a Y Group hospital”. This preserves branded search and reviews, keeps the doctors comfortable, and gives the group brand a slow, safe entry. The cost is that the group brand does not really arrive, and in the demand data the unit remains what it was.

Replace the name outright. This is what the committee usually wants and what the flagship’s brand team argues for. Branded search for the old name drops over months and branded search for the new name does not simply replace it — some of the catchment stops recognising the hospital altogether. Listings have to be renamed or re-created, aggregator profiles migrated, every doctor’s own listing updated, and the contact centre retrained to answer to both names for a year. It can work. It works when the group brand already carries in that city and when the senior doctors are contractually and emotionally on board. Absent both, it is a demand reset dressed up as a brand decision.

Hyphenate for a defined period, then switch. This is the compromise and it is usually the right one, but only if the switch date is real. I have seen a “transitional” double name become permanent because nobody owned the second step, and the unit ended up with the worst of both: two names in the market, two listings competing in search, and no clear entity for anyone to attach a review to.

O&M: a hospital you run and a brand you share

Operations and management contracts are attractive to a group that wants footprint without capital. A trust, a developer or a family owns the building and the licence; the group brings clinical governance, systems and, usually, its name. The committee sees asset-light growth. The digital function should see a contract that decides, clause by clause, what the demand engine is allowed to be.

The questions that matter are unglamorous. Whose name is on the listing, and who verifies it? Whose domain does the site sit on? Who owns the enquiry data in the CRM? Who is entitled to run paid search on the hospital’s name and in whose account? If the contract ends in seven years, who keeps the reviews, the listing, the doctor pages, the social presence, the phone number? I have seen these left unspecified and then fought over at exit, with the group’s brand attached to a hospital it no longer had any say in.

The naming is a compromise by construction. “Managed by” is the common form, and it means the owner’s name leads. The group brand is present but not dominant, which in demand terms means the group’s branded search does not fully accrue to the unit and the unit’s reviews do not fully accrue to the group. For a group that measures brand as a single aggregated score, O&M units are a permanent complication.

The operational reality is that you are building a demand engine for a hospital whose brand you only partly control, on assets you may have to hand back, with a doctor base that was recruited by someone else. It can be a very good business. It is a poor place to put the group’s most important brand promises.

What each route does to the group brand

Step back from the unit and look at the group. Every route changes what the name means in the market.

• Greenfield extends the brand exactly as it is. Whatever the flagship promises, the new unit promises, and the catchment will hold it to that from day one.
• Brownfield imports someone else’s reputation into the brand. For a year or more, the group’s aggregated review score, its aggregator ratings and its branded search sentiment carry the acquired unit’s history. If you are buying several, the group brand becomes an average of what you bought.
• O&M lends the brand to an operation you do not fully control. Every incident at the managed unit attaches to the group’s name in search and in the press, and the group’s ability to fix the cause is bounded by the contract.

None of this argues against any route. It argues for the growth function to say, in the committee, what the brand exposure is and what it will cost to manage — before the capital, timeline and control arguments settle the question by themselves.

The digital work each route creates

For a greenfield: one entity, one listing, one site section, a pre-launch demand programme of a year or more, a doctor-page build as clinicians are hired, and a contact centre queue that exists before the hospital does. Expensive in time, clean in outcome.

For a brownfield: an audit of everything inherited — listings claimed and unclaimed, duplicates, aggregator profiles, domain and site, review history by theme, doctor pages and which ones carry traffic, existing paid accounts and who controls them. Then a migration plan with a named owner and a date for every rename, redirect and re-verification. Then a year of answering to two names. This is the route where the digital cost is most often left out of the deal model, and it is not small.

For an O&M: contract clauses first, then a shared-brand listing and site structure that reflects what was agreed, a CRM instance whose data ownership is documented, and a reporting line that lets the owner see demand performance without owning the engine. Less build than a greenfield, less migration than a brownfield, more governance than either.

What I would do differently

I would insist on the digital footprint audit being part of brownfield diligence rather than post-close discovery. The number of duplicate listings, the unclaimed aggregator profiles, the review themes and the concentration of traffic in two or three doctors’ names were all knowable before signing, and they changed what the unit was worth to us.

I would put a rename decision, with a date, in the deal approval itself. Not signage — the name on the entity, the listing and the site, and the plan to get there.

And for O&M, I would treat the exit clauses on digital assets as seriously as the clauses on equipment. The equipment is the owner’s. The reviews, the listing and the enquiry history are what the group’s brand actually leaves behind.

If the committee is choosing a route next quarter

1. Before the route is chosen, table a one-page brand and demand view of each: what is inherited, what is built, what is shared, and the digital cost of each.
2. For a brownfield target, run the footprint audit during diligence: listings, reviews by theme, doctor-page traffic concentration, domain and account ownership.
3. Put the naming decision and its date into the approval paper. Name the owner of the migration.
4. For a greenfield, carry the full pre-launch demand cost and a ramp assumption based on whether the group has branded search in that city.
5. For an O&M, get the digital asset and data ownership clauses drafted before the commercial terms close, including what happens at exit.
6. Agree how the new unit will appear in the group’s brand and review reporting, so that an inherited score does not silently reset the group’s number.
7. Set up a single review, monthly for the first year, where the unit head, the medical director and the growth function look at branded search, enquiry volume and review sentiment together.

The route decides the capital. The footprint decides whether anyone finds the hospital afterwards.

Questions people ask